Going Global with Spectral Flow Cytometry - US, EU and Now Australia

The Conversational Flow - An Official Podcast of KCAS

During this special episode of "The Conversational Flow" our hosts, Brian and Adam, welcome two guests: John Bucksath, CEO of KCAS Bio, and Stefan Cross, CEO of Crux Laboratories. These two guests discuss the elements and advantages of their organizations' new partnership between KCAS' US and European locations and Crux's location in Melbourne, Australia. Recent months have seen the three locations (Crux in Melbourne, and KCAS's Philadelphia and Lyon facilities) collaborate with Cytek to globalize the use of KCAS' multiple Cytek Aurora platforms and offer advanced spectral flow cytometry universally to their customers around the world. Learn about all the things that have gone into this global adventure, and see what it might mean for you and your team's flow cytometric needs.
“The Conversational Flow” an official podcast of KCAS Bio, and focuses on the more niche topic of Flow Cytometry and its role within the greater pharmaceutical, biopharmaceutical and bioanalytical industries. Every month, KCAS Bio will bring you another 60 minutes (or so) of friendly banter between our two finest Flow Cytometry experts as they chat over coffee and discuss what they’ve learned about the world of Flow Cytometry the past couple of weeks. “The Conversational Flow” is brought to you by KCAS Bio.
KCAS Bio is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA, and Lyon, France, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the pharmaceutical, biopharmaceutical, animal health and medical device industries.